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Abstract 
Transmembrane tyrosine kinase receptors are involved in cellular interactions which promote proliferation and differentiation of many cell types. 
To identify receptor tyrosine kinases important in embryonic hematopoietic ell development we have utiliied the polymerase chain reaction (PCR) 
and degenerate oligonucleotides for isolation of such genes from mouse yolk sac and fetal liver. Sequence analysis of PCR amplified cDNAs from 
these hematopoietic sites of day 8 and 14 embryos, resulted in the isolation of nine tyrosine kinase and three serineithreonine kinase related clones. 
Two of these receptors, tek andftk-I, are expressed in both yolk sac and fetal liver and have been shown previously to be important for endothelial 
cell development. Two other clones, 9B4 and 9A2 appeared novel upon isolation but have been recently described as ryk and SK2 (rat homologue). 
Here we describe the twelve isolated kinases, the specific expression patterns of&-l, tek and ryk kinases and their potential relationship to the 
development of the hematopoietic system. 
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1. Introduction 
In the vertebrate embryo, cellular interactions and 
subsequent intracellular events promote the pluripotent 
hematopoietic stem cell to expand and differentiate into 
the diversity of cell types found in circulating blood and 
hematopoietic tissues. Cells with hematopoietic activity 
have been found at day 7 in the embryonic yolk sac, a 
few days later in the fetal liver and finally in the adult 
bone marrow [l-3]. In addition, the aorta, gonad, mes- 
onephros region (AGM) in the developing embryo has 
recently been reported to contain hematopoietic precur- 
sors [4]. The timing and degree of multipotency of hema- 
topoietic stem cells in these different regions has been 
studied extensively. However, the molecular mechanisms 
which control the early steps of development in the verte- 
brate blood lineages are not well understood. 
A number of specific growth factors and their cognate 
receptors have been found to be involved in the produc- 
tion of functional hematopoietic ell types [5]. One fam- 
ily of genes, the receptor tyrosine kinase (RTK) gene 
family, have been shown to be impo~ant components of 
the signalling pathways by which cells interact [6,7]. 
These molecules are st~cturally and functionally related 
enzymes that show a high degree of conservation be- 
tween species [8]. The structure of these proteins includes 
an extracellular ligand binding domain, a transmem- 
brane domain and an intracellular portion containing 
the catalytic domain. When a specific ligand binds to its 
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receptor, the effect is mediated by the catalytic activities 
of the receptor through phosphorylation of specific in- 
tracellular protein targets [6]. 
Several members of this large gene family have demon- 
strated function in the hematopoietic system. Amongst 
the best characterized are the ~lony-stimulating factor-l 
receptor (CSF-1R) [9], the platelet-derived growth factor 
receptor (PDGFR) [lo] and c-kit [11,12]. These RTKs 
and their ligands play multiple roles. The pivotal roles 
of these RTKs during development is supported by the 
mouse mutants IV/Dominant white spotting (c-kit recep- 
tor mutants), SI (SCF mutants) [2], patch (a PDGFa 
receptor mutant) [133, and op (a CSF-1 mutant) [ 141. 
Other RTKs that may have some overlapping functions 
in several celi types include fetal liver kinase-1 and -2 
@k-I andpk-2) and tek [15-l 71. TheJlk-l andfik-2 genes 
were cloned from a population of fetal liver cells enriched 
for hematopoietic stem cell activity and may therefore be 
important in hematopoiesis. The receptors tek andJik-l 
have been implicated in endothelial cell development and 
yolk sac blood island formation, which may suggest that 
these receptors are utilised by both endothelial and he- 
matopoietic precursors. 
With the importance and abundance of RTKs in he- 
matopoiesis as a precedent, we initiated studies to isolate 
novel tyrosine kinase genes that may play an important 
role in embryonic yolk sac and fetal liver hematopoietic 
development by reverse transcription and polymerase 
chain reaction (RT-PCR). We report here the abundance 
of various tyrosine kinases in these hematopoietically 
active tissues and the expression patterns of three RTK 
genes in tissues of the developing mouse embryo and 
adult and various hematopoietic ell lines. 
All rights reserved. 
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2. Materials and methods 2.5. Isolation and characterization of cDNA clones 
The RT-PCR products represent&g clones 9A2, 9B4 and tek were 
used as nrobes to screen as ohao(dThnimed WEHI- cDNA librarv in 
Igtll (kindly provided by G-Goodwin, London) in order to obiain 
longer cDNAs. Using standard conditions, three overlapping clones of 
9A2 and one clone representing 9B4 were isolated. 
2.1. Mice 
Mice (A Thy 1 and CBA) were obtained from the breeding unit at 
NIMR, Mill Hill and all animal care was in accordance with the Ani- 
mals Scientific Procedures Act, Home Office, UK. 
2.2. Cell lines 
WEHI- (monocyte/macrophage) cells were maintained in Dul- 
becco’s modified Eagle medium (DMEM) supplemented with 10% FCS 
(G&co) and antibiotics. The IL-3 dependent mouse cell line A4 (FDCP 
mix-M) [18] established from a long-term bone marrow culture was 
grown in Fischer’s medium supplemented with 20% horse serum 
(G&co) and 10% WEHI- conditioned medium (containing IL-3) [ 181. 
The pre-B cell line BaF3 [ 191 was cultured in standard DMEM medium 
supplemented with WEHI- conditioned medium. The ABl embryonic 
stem cells (ABl-ES cells) were maintained on confluent feeder layers 
of mitotically inactivated STO-neo embryonic fibroblasts [20]. The 
growth medium used for ES-culture consisted of DMEM, 20% FCS, 
0.1 mM 2-mercaptoethano1, 1 x non-essential amino acids, 10 U/ml 
penicillin and 10 &ml streptomycin. Differentiation of ES cells was 
carried out essentially as described by Doetschmann [29]. 
2.3. RT-PCR, cDNA cloning and sequence analysis 
First strand cDNA was synthesized using 5pg of RNA, oligo(dT),,_,, 
primer (Amersham) and avian myeloblastosis reverse transcriptase 
(Promega). cDNAs were amplified using the degenerate oligonucleo- 
tides, PTKl and PTK2 (1 pg each) de&bed by Wilks [2i] using a 
Techne PHC2 with the following narameters: denaturate 1.5 min at 
95”C, anneal 2 min at 37°C and-extend 3 min at 65°C for 30 cycles. 
Products were analysed on a 1.3% agarose gel (a -210 bp fragment 
indicated amplified kinase related sequences) and cloned into Bluescript 
plasmids after ethanol precipitation, digestion with EcoRI and BamHI 
(sites incorporated into the ohgonucleotides) and gel purification. After 
screening transformants for the presence of the insert, positive clones 
were sequenced using the USB Sequenase kit (Stratagene, UK) and 
database (FASTA program) comparisons were performed. Yolk sac 
transformants were screened using a probemix of PCR products iso- 
lated from fetal liver prior to isolation, characterization and sequencing 
to avoid duplication of clones already isolated from fetal liver. 
2.4. RNA extraction and Northern blot analysis 
Total RNA was extracted using two different methods. For abun- 
dant tissues we utilized the LiCUurea method [22]. Briefly, frozen or 
fresh tissues or cells were homogenised in 3 M LiCl, 6 M urea (5 ml/g), 
sonicated and kept overnight at &4”C. The RNA was pelleted 
(15,000 x g) and reprecipitated in a ‘/z volume of cold LiCYurea. After 
centrifugation the pellet was dissolved in 10 mM Tris pH 7.6, 1 mM 
EDTA and 0.5% SDS, extracted once with phenol/chIoroform/isoamyl- 
alcohol (25 : 24: l), once with chloroform and ethanol-precipitated. 
Total RNA from small amounts of tissue (1 S-60 pooled yolk sacs and 
embryos) day 8.5 was extracted with RNAzol (Biotecx Lab. Inc., USA) 
according to the suppliers specifications. Briefly, the tissue was homo- 
genised with RNAzol (0.8-2 ml depending on the amount of tissue), 
mixed with a ‘/,,, volume of chloroform and left on ice for 5 min. The 
suspension was centrifuged for 15 min, the aqueous phase collected and 
RNA precipitated with a ‘/z volume of isopropanol. 
For Northern blot analysis, 2Opg of total RNA was fractionated on 
a 1.3% agarose gel containing 6% formaldehyde and transferred to a 
Genescreen Plus nylon membrane using standard conditions. The mem- 
branes were hybridised with ‘2P-labelled antisense riboprobes synthe- 
sized from RT-PCR cDNA products of clones 9B4,Jlk-1 and tek. The 
RT-PCR cDNA nroducts and longer cDNA clones isolated from 
cDNA libraries representing 9B4 and tek were labelled by the random 
priming method (a tek cDNA was kindly provided by D. Dumont and 
M. Breitman). Hybridisation was carried out in 60% formamide, 1 x 
Denhardt’s solution (0.1% of Ficoll, polyvinylpyrolidone and bovine 
serum albumin), 5 x SSC, 20 mM sodium phosphate buffer pH 6.8, 1% 
SDS, 7% dextran sulfate and 100 &ml of each of denatured salmon 
sperm DNA and baker’s yeast tRNA and 10 &ml poly(A)RNA at 
65°C for 1624 h. Filters were washed in 2 x SSC, 1% SDS at 50°C and 
in 0.2 x SSC, 1% SDS at 80°C and autoradiographed. 
2.6. Western blot analysis 
Cell lysates were prepared from the BaF3 cell line and mouse embry- 
onic heart (day l&l 1). Cells and tissues were incubated in lysis buffer 
(10 mM Tris pH 7.5,20 mM EDTA and 2% NP40) on ice for 30 min, 
followed by homogenisation and centrifugation for 45 min at 4°C. The 
extracts were separated on a 7% SDS-polyacrylamide gel, transferred 
to Hybond-C extra nylon filters (Amersham, UK) for 4 h at 80 V. The 
filters were blocked for 2 h with 10% bovine serum albumin-phosphate 
buffered saline pH 7.4, 0.1% Tween (BSA-PBT) followed by 2 h block- 
ing in 5% milk-PBT. Thereafter, the filters were incubated with affinity- 
purified tek-antibodies (kindly provided by D. Dumont and M. Breit- 
man) in 5% milk-PBT overnight at 4°C. After antibody incubation the 
filters were washed in PBS and incubated with horseradish peroxidase 
conjugated goat anti-rabbit Ig (Southern Biotechnology), diluted in 5% 
milk-PBT for 1 h at room temperature. The filters were washed exten- 
sively and developed using the chemiluminescence r action (Amer- 
sham, UK). 
3. Results 
3.1. Isolation and sequence analysis of PCR amplljied 
cDNA clones 
To identify and characterize tyrosine kinases poten- 
tially important in early hematopoietic ell development, 
cDNAs were synthesized from RNA isolated from the 
known sites of embryonic hematopoiesis; day 8 yolk sac 
and day 14 fetal liver. Degenerate oligonucleotides corre- 
sponding to the IHRDL and DVWSFG conserved 
amino acid sequences in the catalytic domain, previously 
shown to amplify tyrosine kinases, were used as primers 
for PCR [21]. A total of 22 PCR-amplified clones (ap- 
proximately 210 bp) from day 14 fetal liver were se- 
quenced. This analysis resulted in the identification of 
10 distinct cDNAs representing 8 tyrosine kinases and 
2 serine/threonine kinases (Table 1). In addition, 4 clones 
did not contain any sequence similarity to protein ki- 
nases. Three clones represented in day 14 fetal liver were 
the intracellular tyrosine kinases lyn, fyn and hck (Table 
1). Previously, these kinases have been shown to be ex- 
pressed in cells of the adult hematopoietic system. The 
tyrosine kinase FD17, originally cloned from FDCP- 1 
cells was recovered from the fetal liver at a high fre- 
quency (‘/,,) which may indicate that this gene product 
may play an important role in multipotential hematopoi- 
etic cells during development. Three other clones isolated 
were of the RTKs type: jlk-I, tek and IGFR (insulin 
growth factor receptor) (Table 1). 
To reduce the possibility of isolating intracellular tyro- 
sine kinase cDNAs from day 8 yolk sac, a probe mix 
containing PCR products representing lyn, fyn, hck, 
FD17 (intracellular kinases) and IGFR (isolated from 
day 14 fetal liver) was used in colony hybridization. Non- 
hybridizing transformants were isolated and sequence 
analysis of 16 cDNA clones from day 8 yolk sac revealed 
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4 distinct tyrosine kinases, all of which appeared to be 
of the receptor type (Table 1). Eight clones were homol- 
ogous to jfk-1, 5 to tek and 1 to the basic fibroblast 
growth factor receptor (bFGF) genes. Two clones, 9B4 
isolated from both fetal liver and yolk sac and 9A2 iso- 
lated from fetal liver, appeared novel upon FASTA pro- 
gram sequence analysis. 
Clone 9B4 contains the invariant DFG triplet, the 
conserved tyrosyl residue homologous to the auto- 
phosphorylation site Y-416 in src-kinases [23] and a 
methionine in the second position of the conserved motif 
W(M/T/L)A(A/P)E which is indicative of a transmem- 
brane tyrosine kinase [8]. Furthermore, the upstream 
sequence IHRDLAARN strongly suggests that 9B4 is a 
tyrosine kinase, rather than a serine/threonine kinase [8]. 
This has been confined by recent cloning of the full 
length mouse peritoneal macrophages cDNA encoding 
a putative RTK,ryk [24,25] which shows 100% homology 
to clone 9B4. 
Clone 9A2 shows 100% homology to a serine/threon- 
ine kinase (X2) isolated from a rat large granular lym- 
phocytic cell line [26]. Some homology to the Drosophila 
serine/threonine kinase ninaC gene [27] was found but 
sequence does not belong to any of the classical subfam- 
ilies of serine/threonine kinases [28]. Further expression 
analysis of the 9A2 clone was not pursued. 
3.2. Expression of the tyrosine kinase receptors flk-1, tek 
and !?B4 (ryk) in Morse tissues and hematopoietie c ll 
lines 
To determine whether the isolated kinases were ex- 
pressed in a hematopoietic ell-specific manner, North- 
Table 1 
Protein tyrosine kinase cDNAs isolated from day 14 fetal liver and day 
8 embryonic yolk sac by reverse transc~ption and polymerase chain 
reaction 
Protein tyrosine kinase Number of clones Reference 
dl4 fetai liver 
FD17 
lyn 
hck (bmk) 
ryk (9B4) 
IGFR 
fVn 
tek 
j?k-I 
PAZ* 
9BI 
_ 
5 21 
2 46 
2 47 
2 24,25,40 
1 48 
1 49 
1 17 
1 1s 
1 26 
2 Sermr homologue 
4 unrelated 
d8 embryonic yolk sac 
Jk-I 
tek 
ryk (9B4) 
bFGFR 
8 15 
5 17 
2 24,25,40 
1 50 
*A serine/threonine kinase. 
ern blot analysis was performed on embryonic, fetal and 
adult mouse tissues and on mouse cell lines for the RTKs 
j&-f, 9B4 and tek (Figs la, b and c, respectively). These 
data are summarized in Table 2. 
In early stage embryos (day 8-10 of mouse gestation), 
transcripts for all three RTKs; Jtk-I, tek and ryk were 
detected at one or several stages in both the yolk sac and 
the body of the embryo. At later stages (day 12-14 of 
gestation),$k-2 and ryk mRNA were observed in fetal 
liver. However, no tek expression was seen. Since we 
were able to clone a cDNA for tek from day 14 fetal liver 
using RT-PCR (Table l), the level of tek expression must 
be below the limits of detection using total RNA in 
Northern blot analysis. 
When the relative levels of expression were examined 
in these tissues, amounts of tek and flk-Z mRNA ap- 
peared to decrease as the age of the embryo increased. 
Tek specific transcripts were detectable up to day 11 in 
the embryo but were not detected in day 11 yolk sac or 
day 14 fetal liver. Flk-Z was found in day 10 yolk sac and 
embryo body but decreased greatly from day 12 to day 
16 (undetectable) in the fetal liver. This correlates well 
with the abundant isolation offtk-1 cDNA clones (eight) 
from day 8 yolk sac while only one JNC-1 cDNA was 
cloned from day 14 fetal liver by RT-PCR (Table 1). In 
contrast to #k-I and tek, ryk expression was found to 
increase in the yolk sac and embryo from day 8 to day 
9 and remain relatively constant throughout develop- 
ment up to day 14 in fetal liver. In addition, we examined 
flk-I and ryk expression in ES cells which have been 
shown to differentiate into various hematopoietic line- 
ages [29,30] and express hematopoietic specific genes in 
a developmentally controlled manner [3 1,321. Flk-2 tran- 
scripts were found in ~d~erentiated and day 9 differen- 
tiated cells but no or UndetectablefNc-Z expression was 
observed after 11 days of differentiation. This decrease 
in expression during development corresponds to that 
seen in yolk sac (Fig. la) and in 6.5 day differentiated ES 
cells [33]. Ryk expression was observed in both day 9 and 
day 11 differentiated embryoid body cells (Fig. lb). 
In the adult mouse, high levels ofJEk-I and tek expres- 
sion were observed in lung and heart and lower levels 
were observed in the brain. Flk-1 was also expressed at 
abundant levels in kidney and muscle. In the hematopoi- 
etic tissues (BM, LN and thymus), jfk-I could be de- 
tected at very low levels (see Table 2) while no tek expres- 
sion was detected. The ryk RTK (Fig. lb) appears to be 
expressed in almost all hematopoietic and non-hemato- 
poietic tissues (no expression in spleen). 
Finally, hematopoietic cell lines FDCP-A4 and 
WEHI- and a non-hematopoietic ST0 cell line were 
examined for RTK expression by Northern blot analysis. 
FDCP-A4 and WEHI- but not ST0 cells were found to 
express jZk-I. Whereas all embryonic and adult tissues 
expressed only a 5.5 kb$k-I transcript [36,371, cell lines 
produced two additionalpk-l transcripts. The ryk RTK 
122 
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C. tek 
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b. ryk 
Fig. 1. Expression of: (a)_/Ik-1, (b) ryk and (c) tek mRNA using Northern blot analysis. Embryonic, fetal and adult mouse tissues and three cell lines 
(FDCP-A4, WEHI-3B and STO) were tested. Twenty pg of total RNA was used in each lane. Abbreviations used for embryonjc and fetal tissues: 
ES-O = undifferentiated embryonic stem cells; ES-9/l 1 = embryonic stem cells differentiated for 9 respectively 11 days in vitro; YS = yolk sac; 
Emb = embryo; FL = fetal liver. Adult tissues: LN = lymph node; S = spleen; K = kidney; U = uterus; Lv = liver; M = muscle; T = thymus; 
Lu = lung; H = heart; Br = brain; and BM = bone marrow. Arrows indicate predominant transcript. (d) Western blot analysis of tek protein 
expression. Lysates of embryonic heart (day 10-l 1) and the BaF3 cell line were analysed for the presence of tek protein using purified tek antibodies. 
The tek antibody detects a 140 kDa protein in the embryonic heart preparation and a slightly bigger protein, 150 kDa, in the BaF3 cell line. The 
positions of the molecular weight markers are depicted on the left. 
was found to be highly expressed in both FDCP-A4 and 
WEHI- cell lines. Two transcripts were observed, a 3.5 
kb band and more abundant 2.8 kb band and correspond 
to those previously reported [24,25]. ST0 cells produced 
low levels of tek transcripts while FDCP-A4 and WEHI- 
3 cells were negative. The tek transcripts in all the tissue 
and ST0 cell RNAs tested were comparable to the previ- 
ously published 4.5 kb size, except for the lung where 
multiple additional smaller transcripts were found. Some 
of these correspond to the other three transcripts re- 
ported by Dumont et al. [17] in embryonic heart. 
To investigate whether tek protein was expressed in 
any hematopoietic ell lines, Western blot analysis was 
performed on WEHI- and P338Dl monocyte/macro- 
phage lines, the EL4 T cell line, MEL cells (erythroleuke- 
mic) and the pre-B cell line BaF3. Embryonic heart ex- 
tracts (day l&l 1) were used as a positive control for tek 
protein expression, No expression was observed in either 
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of the macrophage cell lines, the T-cell line or the MEL 
cells (data not shown). However, in the BaF3 pre-B cell 
line, the affinity-purified tek antibodies recognized a pro- 
tein of approximately 150 kDa (Fig. Id). A 140 kDa 
protein can be detected in the control embryonic heart 
extract and corresponds to the previously reported size 
of the tek protein in day 13.5 embryonic heart and endo- 
thelial cell lines [38]. The unglycosylated, predicted size 
of tek estimated from the deduced amino acid sequence 
is 126 kDa [36]. The slightly larger size protein detected 
in the BaF3 cell line may indicate that tek occurs in an 
alternative glycosylated form as compared to that found 
in heart or endothelial cells. 
4. Discussion 
We have described the isolation of 12 distinct protein 
tyrosine kinase cDNAs from embryonic yolk sac and 
fetal liver using degenerate oligonucleotides and RT- 
PCR and have also described the expression patterns of 
three of these: fNc-I, tek and ryk in the mouse and in 
tissue culture cells. Theflk-1 RTK, isolated from both 
the yolk sac and the fetal liver, was detected in RNA 
from embryonic stem cells, embryoid bodies, yolk sac 
and the developing embryo. It appears thatflk-Z is one 
of the most abundant RTKs in the yolk sac (representing 
8 of 16 cloned sequences). While its expression level de- 
creases during development, it is highly expressed in the 
adult heart and lung but can also be detected in some 
hematopoietic tissues and cell lines. Similarly, we have 
shown that tek is a frequently represented RNA in the 
early developing mouse yolk sac (5 of 16 cloned and 
sequences). Its expression decreases as the embryo ma- 
tures. In the adult, it is expressed predominantly in the 
heart and lung. Although tek RNA is not detected in any 
adult hematopoietic tissues we have found tek protein in 
a pre-B hematopoietic ell line. 
BothJlk-I and tek have been implicated in endothelial 
cell differentiation [17,33,34] by in situ hybridisation of 
endothelial cells and their presumptive precursors. In the 
yolk sac blood islands of day 7.25-8.5 embryos, studies 
have shown that$k-2 is expressed earlier and in a more 
primitive endothelial precursor cell than tek [33]. This 
primitive precursor, the hemangioblast, is believed to be 
the common precursor for both the endothelial and 
hematopoietic ell lineages. Angioblasts (the committed 
endothelial progenitor) of the yolk sac, express both 
JEk-I and tek. While day 8.5 embryonic yolk sac contains 
hemangioblasts, angioblasts and endothelial cells, hema- 
topoietic progenitors for the B lymphoid, myeloid and 
erythroid lineages are also present in the blood islands 
[1,2,36]. Due to this colocalization, Jlk-I and tek may 
play a role in hematopoiesis or lineage commitment 
events. It is interesting to note that Jlk-I is expressed in 
fetal liver cells enriched for hematopoietic stem cell activ- 
ity [15] and in the bone marrow derived hematopoietic 
progenitor cell line FDCP-A4 (Fig. lc). Also, ES cells 
differentiated for 9 days which contain identifiable he- 
matopoietic blood islands [29] as well as endothelial cells 
[38,39] were found to expressflk-I. These data together 
with the published data [33,34] may suggest a role for 
jlk-I in early hematopoietic ell development. We have 
found tek protein in a pre-B cell line suggesting that this 
putative RTK may have a very limited or secondary role 
in the adult hematopoietic system. Perhaps theflk-1 and 
tek RTKs, like many other growth factor receptors 
(c-kit, for example), have multiple roles in different cell 
types. 
We have shown that the 9B4 clone, ryk, is ubiquitously 
expressed in most hematopoietic and non-hematopoietic 
tissues in the embryonic and adult mouse and at very 
Table 2 
RNA expression analysis of the tyrosine kinase receptors$k-Z, tek and 
ryk (9B4) in mouse tissues and cell lines 
Cell line/Tissue 
EmbryoniclFetal 
d0 ES 
d9 ES 
dll ES 
d8 YS 
jlk-I 
+ 
+ 
- 
nt 
tek 
nt 
nt 
nt 
+ 
ryk (9B4) 
nt 
+ 
+ 
_I 
d8 embryo 
d9 YS 
d9 embryo 
d10 YS 
d10 embryo 
dll YS 
dll embryo 
d12 FL 
d13 FL 
d14 FL 
Adult 
thymus 
LN 
spleen 
BM 
liver 
kidney 
uterus 
muscle 
lung 
heart 
brain 
nt 
nt 
+ 
+ 
+ 
nt 
nt 
+ 
f 
+ 
-3 
-3 
- 
-3 
- 
+ 
- 
+ 
-I- 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
- 
+ 
nt 
nt 
-2 
- 
- 
nt 
- 
nt 
nt 
nt 
nt 
+ 
+ 
+ 
+ 
+ 
- 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
Cell lines 
FDCP-A4 + - + 
WEHI- + - + 
ST0 - - + 
’ ryk was cloned from d8 YS. 
’ tek was cloned from d14 FL. 
‘These tissues have shown expression ofJik-I but at very low levels 
(data not shown). 
nt = not tested; ES = embryonic stem cells; YS = yolk sac; FL = fetal 
liver; LN = lymph node; BM = bone marrow. 
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high levels in hematopoietic ell lines. Both the mouse 
and human full-length cDNAs have recently been iso- 
lated [24,25,40] and analysis of the extracellular and cat- 
alytic kinase domains revealed that ryk does not fall into 
any of the previously defined classes of protein tyrosine 
kinases [8] although retaining associated features. The 
human homologue was cloned from the human leukemia 
cell line K562 and was shown to be widely expressed in 
both adult human tissues and tumor cells of different 
origins [40,41]. What specific role ryk may play in the 
hematopoietic system remains to be elucidated. 
It appears from our studies and those of others 
[ 17,41,42,43] that the degenerate oligonucleotides PTKl 
and PTK2 have reached the extent of their usefulness in 
the isolation of novel embryonic and fetal RTK genes. 
We were unable to isolate even a single novel clone by 
sequencing the 210 base region. Perhaps only the most 
abundant receptor and intracellular tyrosine kinases are 
easily amplified or alternatively, some cDNAs may be 
cloned more easily with respect to the degenerate ol- 
igonucleotides used. It is interesting to note that the same 
spectrum of clones has been isolated from many different 
tissue types [ 17,24,26,41,43,44]. Using this particular 
cloning strategy, a level of saturation has been reached. 
Therefore in order to isolate new RTKs it could be more 
useful to design oligonucleotides for other regions of 
conserved domains or perform more stringent subtrac- 
tion procedures with existing kinase genes. A procedure 
with nested PCR primers has been used for the isolation 
of the ryk RTK [24]. In parallel, it will probably be useful 
to isolate the cell population or single cells [45] of interest 
prior to applying a particular cloning strategy. 
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